• 
  Diabetes and Auditory-Vestibular Pathology

  Semin Hear 2019; 40: 292-299DOI: 10.1055/s-0039-1697033The relationship between diabetes mellitus (DM) and the auditory/vestibular system has been investigated for more than a century. Most population-based investigations of hearing loss in persons with diabetes (PWD) have revealed a slow progressive, bilateral, high-frequency sensorineural hearing loss. Despite the growing research literature on the pathophysiology of DM-related hearing loss usi

  Hearing

  Tue Oct 08, 2019 16:00
• Evaluation and Management of Patients with Diabetes and Hearing Loss

  Semin Hear 2019; 40: 308-314DOI: 10.1055/s-0039-1697644Diabetes mellitus is a significant risk factor for acquired hearing loss and tinnitus. Persons with diabetes (PWD) may present with hearing loss symptoms earlier in life than those without diabetes. Furthermore, diabetes may exacerbate risk for hearing loss related to noise exposure and ototoxic drugs. The purpose of this article is to provide recommendations for the prevention, screening, ev

  Hearing

  Tue Oct 08, 2019 16:00
• Epidemiology of Diabetes and Hearing Loss

  Semin Hear 2019; 40: 281-291DOI: 10.1055/s-0039-1697643Hearing loss is a highly prevalent chronic condition. In addition to age, sex, noise exposure, and genetic predisposition, cardiovascular disease and its antecedents may precipitate hearing loss. Of emerging interest is the connection between diabetes and auditory dysfunction. Cross-sectional studies consistently suggest that prevalence of hearing loss is higher in persons with diabetes compa

  Hearing

  Tue Oct 08, 2019 16:00
• Diabetes and the Vestibular System

  Semin Hear 2019; 40: 300-307DOI: 10.1055/s-0039-1697032Falls are among the most injurious, costly, and feared conditions affecting older adults. Patients with diabetes have a significantly greater risk for falling due to complications affecting the sensory systems required for balance: vision, proprioception, and vestibular. The effects of diabetes mellitus on the vestibular system are perhaps the least understood of these systems. The vestibular

  Hearing

  Tue Oct 08, 2019 16:00
• Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes

  Semin Hear 2019; 40: 315-326DOI: 10.1055/s-0039-1697645As of September 10, 2019, there were 75 medications (oral/injectable/inhalants) approved by the U.S. Food and Drug Administration for diabetes management: 1 inhalant, 21 oral combinations, 22 injectable, and 31 oral medications (not in combination with any other diabetes drug). This article isolates the auditory and vestibular side effects of those drugs as reported by the drug's manufacturer

  Hearing

  Tue Oct 08, 2019 16:00
• The Role of Audiology in the Care of Persons with Diabetes

  Semin Hear 2019; 40: 279-280DOI: 10.1055/s-0039-1697031Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals:Table of contents  |  Full text

  Hearing

  Tue Oct 08, 2019 16:00